Alnylam Pharmaceuticals announces interim Phase 1 data of nucresiran
Pharmaceuticals announced the presentation of new results from its Phase 1 study of nucresiran, a next-generation RNAi ...
Business Insider8 小时
Alnylam Presents New Phase 1 Results For Next-Gen RNAi Therapy Nucresiran In ATTR Amyloidosis
The data were presented in an oral session at the American Heart Association Scientific Sessions 2024 in Chicago. The new results demonstrated that a single dose of nucresiran at 300 mg or higher led ...
China Doctor Attempts To Treat Girlfriend's Insomnia By Injecting Anaesthetics, She Dies
According to the South China Morning Post, he caused his girlfriend's death by attempting to treat her insomnia with repeated ...
BuzzFeed on MSN4 小时
The Holiday Season Is Fun, But Holiday Travel….Not So Much. These 43 Products Can Help
Santa doesn't have any room on his sleigh for you, so you'll have to make do with a commercial airline. Prepare accordingly.
Kodiak Sciences Inc.: Kodiak Sciences Announces Recent Business Highlights and Third ...
Kodiak Sciences Inc. (Nasdaq: KOD), today reported business highlights and financial results for the quarter ended ...